GlycoNex (TWO:4168) — Stock Price
GlycoNex (TWO:4168) is currently trading at NT$22.95 TWD, down 0.22% today. Over the past 52 weeks, shares have ranged between NT$20.80 and NT$29.40. This page tracks GlycoNex's live share price on the TWO exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see GlycoNex stock valuation.
GlycoNex (4168) Stock Price Chart — Daily History & Trading Volume
The chart below tracks GlycoNex's daily closing share price and trading volume on the TWO exchange over the past year, giving a clear view of recent price momentum and liquidity.
GlycoNex Income Statement — Revenue, Profit & Earnings by Year
GlycoNex's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Revenue | NT$14.70 Million | NT$2.54 Million | NT$30.09 Million | NT$5.47 Million | NT$451.00K |
| Cost of Revenue | NT$7.38 Million | NT$1.55 Million | NT$16.12 Million | NT$2.01 Million | NT$326.00K |
| Gross Profit | NT$7.32 Million | NT$995.00K | NT$13.97 Million | NT$3.46 Million | NT$125.00K |
| Research & Development | NT$204.55 Million | NT$210.38 Million | NT$197.41 Million | NT$145.01 Million | NT$156.99 Million |
| SG&A | NT$48.88 Million | NT$45.27 Million | NT$50.78 Million | NT$48.85 Million | NT$52.47 Million |
| Total Operating Expenses | NT$260.82 Million | NT$260.86 Million | NT$252.61 Million | NT$198.39 Million | NT$214.24 Million |
| Operating Income | NT$-246.12 Million | NT$-158.00 Million | NT$-215.16 Million | NT$-172.49 Million | NT$-158.94 Million |
| EBITDA | — | NT$-126.83 Million | NT$-175.20 Million | NT$-132.36 Million | NT$-112.35 Million |
| EBIT | — | NT$-158.00 Million | NT$-215.16 Million | NT$-172.49 Million | NT$-158.94 Million |
| Interest Expense | NT$5.71 Million | NT$5.71 Million | NT$4.36 Million | NT$182.00K | NT$2.48 Million |
| Income Before Tax | NT$-229.68 Million | NT$-163.72 Million | NT$-219.82 Million | NT$-172.49 Million | NT$-161.41 Million |
| Income Tax Expense | — | NT$14.64 Million | — | — | NT$1.32 Million |
| Net Income | NT$-229.71 Million | NT$-178.36 Million | NT$-219.82 Million | NT$-172.49 Million | NT$-162.73 Million |
GlycoNex Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes GlycoNex's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Assets | NT$1.32 Billion | NT$1.55 Billion | NT$1.72 Billion | NT$1.40 Billion | NT$1.57 Billion |
| Total Current Assets | NT$481.20 Million | NT$718.33 Million | NT$713.13 Million | NT$358.69 Million | NT$499.16 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | NT$332.60 Million | NT$550.31 Million | NT$596.58 Million | NT$206.53 Million | NT$326.22 Million |
| Net Receivables | NT$0.00 | NT$25.00K | NT$46.00K | NT$350.00K | NT$16.00K |
| Inventory | — | — | — | — | — |
| Property, Plant & Equipment | — | — | NT$989.92 Million | NT$1.02 Billion | NT$1.05 Billion |
| Goodwill | — | — | — | — | — |
| Total Liabilities | NT$270.01 Million | NT$276.40 Million | NT$271.34 Million | NT$36.07 Million | NT$34.47 Million |
| Total Current Liabilities | NT$264.63 Million | NT$270.58 Million | NT$44.48 Million | NT$27.21 Million | NT$25.57 Million |
| Long-term Debt | — | NT$0.00 | NT$218.68 Million | NT$0.00 | NT$0.00 |
| Net Debt | — | NT$-148.57 Million | NT$142.39 Million | NT$-124.17 Million | NT$-151.84 Million |
| Total Stockholder Equity | NT$1.05 Billion | NT$1.28 Billion | NT$1.45 Billion | NT$1.36 Billion | NT$1.54 Billion |
| Retained Earnings | NT$-229.37 Million | NT$-178.11 Million | NT$-218.70 Million | NT$-172.65 Million | NT$-160.00 Million |
GlycoNex Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how GlycoNex generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | NT$-221.97 Million | NT$-183.92 Million | NT$-167.55 Million | NT$-140.86 Million | NT$-145.59 Million |
| Capital Expenditures | NT$35.28 Million | NT$23.42 Million | NT$8.69 Million | NT$6.84 Million | NT$1.87 Million |
| Free Cash Flow | NT$-257.24 Million | NT$-207.34 Million | NT$-176.24 Million | NT$-147.70 Million | NT$-147.46 Million |
| Investing Cash Flow | — | — | NT$-399.57 Million | NT$113.22 Million | NT$-199.68 Million |
| Financing Cash Flow | — | NT$-6.72 Million | NT$524.24 Million | NT$-27.00K | NT$379.27 Million |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | — | NT$0.00 | NT$3.34 Million | NT$-2.83 Million | NT$11.18 Million |
| Depreciation | NT$34.37 Million | NT$31.18 Million | NT$39.96 Million | NT$40.13 Million | NT$46.59 Million |
| Change in Cash | NT$-39.96 Million | NT$67.28 Million | NT$-42.88 Million | NT$-27.67 Million | NT$34.00 Million |
GlycoNex Earnings History — EPS Actual vs. Analyst Estimates
Track GlycoNex's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| May 31, 2023 | -0.55 | — | — |
| Mar 01, 2023 | -0.67 | — | — |
| Nov 30, 2022 | -0.64 | — | — |
| Aug 31, 2022 | -0.58 | — | — |
| Jun 01, 2022 | -0.32 | — | — |
| Mar 02, 2022 | -0.48 | — | — |
| Dec 01, 2021 | -0.42 | — | — |
| Sep 01, 2021 | -0.42 | — | — |